GlassScriptPhysician profile
Justin M Watson
NPI 1164606042
$8,762.12
in general payments reported to CMS, 2019-2025
36 companies · $761 in 2025
The $761 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,804 · 2020: $330 · 2021: $205 · 2022: $955 · 2023: $2,485 · 2024: $2,222 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,914 · Travel and Lodging: $2,392 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119 · Education: $35.06 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,913.68 |
| Travel and Lodging | $2,391.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118.97 |
| Education | $35.06 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,010.86 | 2019-2024 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $500.80 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $412.79 | 2019-2024 | Provenge |
| Pfizer INC. | $372.36 | 2019-2025 | |
| Teleflex LLC | $332.31 | 2023 | Urolift |
| Astellas Pharma US INC | $315.72 | 2019-2022 | |
| Cook Medical LLC | $304.81 | 2022-2025 | Litho 150, Fiber Dust |
| Boston Scientific Corporation | $302.87 | 2019-2024 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $300.72 | 2023-2025 | Orgovyx |
| C. R. Bard, INC. & Subsidiaries | $290.57 | 2022-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter, Aptra |
| Myovant Sciences INC. | $240.65 | 2021-2022 | |
| Accord Healthcare, INC. | $144.50 | 2022 | |
| Blue Earth Diagnostics | $135.31 | 2019-2022 | |
| Medtronic, INC. | $115.41 | 2025 | |
| Agiliti Surgical, INC. | $101.76 | 2021-2023 | Sonablate, Trinity, Soltive |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $95.58 | 2022-2025 | Imfinzi, Lynparza |
| Janssen Scientific Affairs, LLC | $82.43 | 2019 | |
| Urogen Pharma, INC. | $73.52 | 2023-2025 | Jelmyto |
| Coloplast Corp | $69.26 | 2024-2025 | |
| Stryker Corporation | $68.00 | 2022 | |
| Merck Sharp & Dohme LLC | $60.73 | 2024 | Welireg, Keytruda |
| Myriad Genetic Laboratories, INC. | $54.55 | 2024-2025 | Prolaris |
| 180 Medical, INC. | $53.13 | 2021-2022 | |
| Ambu INC. | $50.81 | 2021-2024 | |
| Neotract INC. | $47.97 | 2019-2020 | |
| Abbvie INC. | $36.81 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.39 | 2022 | |
| Endo USA, INC. | $23.38 | 2024 | Xiaflex |
| Alnylam Pharmaceuticals INC. | $18.61 | 2023 | Oxlumo |
| Endo Pharmaceuticals INC. | $18.15 | 2019 | |
| Becton, Dickinson and Company | $17.63 | 2022 | |
| Urovant Sciences INC | $16.51 | 2022 | |
| Antares Pharma, INC. | $15.97 | 2019 | |
| Travere Therapeutics, INC. | $15.26 | 2019-2021 | |
| Rochester Medical Corporation | $15.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.